Results 221 to 230 of about 214,597 (337)

Early Enzyme Replacement Therapy Does Not Prevent the Protein Losing Enteropathy Syndrome in Neurovisceral Gaucher Disease

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Gaucher disease (GD) is a rare lysosomal storage disorder characterized by multisystemic involvement. With the advent of enzyme replacement therapy (ERT), patient survival has improved, revealing new long‐term complications. We report a case of a 4‐year‐old male with severe neurovisceral GD who developed protein‐losing enteropathy (PLE ...
Vincenza Gragnaniello   +7 more
wiley   +1 more source

Pharmacological studies of a non-steroidal analgesic and antipyretic drug of LFP83.

open access: bronze, 1989
Kiyoshi Kuriyama   +12 more
openalex   +2 more sources

Diagnostic tests for Helicobacter pylori: comparison and influence of non-steroidal anti-inflammatory drugs. [PDF]

open access: bronze, 1992
Ali S. Taha   +8 more
openalex   +1 more source

Do Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Adversely Impact Fracture Healing? A Critical Review of the Literature. [PDF]

open access: yesCurr Rev Musculoskelet Med
Stroud SG   +8 more
europepmc   +1 more source

Association Between Postoperative Debridement Patterns After Initial Endoscopic Sinus Surgery and Revision Endoscopic Sinus Surgery

open access: yesInternational Forum of Allergy &Rhinology, EarlyView.
Summary 1 versus 0 PDs within 90 days of initial ESS was associated with 11% decreased risk of revision ESS. 2 versus 1 PD or a first PD 8–30 versus 1–7 days after initial ESS did not affect risk of revision ESS. 3+ versus 1 PD or a first PD 31–90 versus 1–7 days after initial ESS was associated with increased risk of revision ESS.
Max J. Hyman   +3 more
wiley   +1 more source

Cerebral Small Vessel Disease in Older Adults With Olfactory Dysfunction

open access: yesInternational Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Poor vascular health has been associated with age‐related declines in sensory functions, including olfaction. The current study was designed to test the hypothesis that cerebral small vessel disease underlies poor olfactory function due to structural declines in brain regions that support olfaction.
Mark A. Eckert   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy